Previous studies have found that epigenetic drugs targeting histone acetylation/deacetylation (HAT or HDAC inhibitors), histone/DNA methylation, or histone methyltransferase activities, modulated experimentally induced peritoneal fibrosis [6,7,8,62]. The gene discussed is HDAC9; the disease is Peritoneal Fibrosis.